AARD Aardvark Therapeutics, Inc. - Common Stock
$4,64
Precio · May 22, 2026
Fundamentales a fecha de May 7, 2026
Rango 52S
$3–$18
9% of range
Calificación del Analista
STRONG BUY
18 analysts
Precio Objetivo
$15
+233% upside
P/E (TTM)
-4.5
ROE
-47.3%
Margen de Beneficio Neto
—
AARD Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$4.63
Capitalización Bursátil
$286M
P/E (TTM)
-4.5
BPA (TTM)
$-2.93
Ingresos (TTM)
$0
Rendimiento div.
—
ROE
-47.3%
Deuda/Capital
—
Rango 52S
$3 – $18
AARD Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
$0
2025-12-31
→
2025-12-31
BPA
$-2.93
2024-12-31
→
2025-12-31
Flujo de caja libre
$-54M
2025-12-31
→
2025-12-31
Márgenes
—
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
AARD
Mediana de Pares
P/E (TTM)
-4.5
22.6
P/B (P/C)
2.7
3.5
Price / FCF (Precio / FCF)
-5.3
—
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
AARD
Mediana de Pares
ROA
-59.2%
-62.6%
ROE
-47.3%
-59.0%
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
AARD
Mediana de Pares
Current Ratio (Ratio corriente)
10.6
2.7
Quick Ratio (Ratio Rápido)
10.4
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
AARD
Mediana de Pares
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
AARD
Mediana de Pares
AARD Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
18 analistas
- Compra fuerte 7 38,9%
- Compra 6 33,3%
- Mantener 5 27,8%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
9 analistas · 2026-05-20
Mediana
$7.00
Media
$15.44
Ahora
$4.63
Mín
$3.00
Máx
$45.00
Objetivo mediano
$7.00
+51,0%
Objetivo medio
$15.44
+233,2%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-0.01%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 31 de marzo de 2026 | $-0.99 | $-0.89 | -0.10% |
| 31 de diciembre de 2025 | $-0.81 | $-0.85 | 0.04% |
| 30 de septiembre de 2025 | $-0.75 | $-0.81 | 0.06% |
| 30 de junio de 2025 | $-0.66 | $-0.61 | -0.05% |
| 31 de marzo de 2025 | $-0.71 | $-0.69 | -0.02% |
Comparación con pares Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| AARD | $286M | -4.5 | — | — | -47.3% | — |
| RANI | — | -3.0 | 58.9% | -1817.1% | -169.6% | — |
| NRXP | — | — | — | — | — | — |
| CGTX | $120M | -4.2 | — | — | -113.7% | — |
| LONA | $71M | -0.3 | — | — | -353.4% | — |
| VRCA | $143M | -4.9 | 370.2% | -50.3% | -492.8% | — |
| CPIX | $60M | -20.9 | 17.6% | -6.4% | -11.9% | — |
| TELO | $46M | -4.0 | — | — | -325.7% | — |
| PLRX | $75M | -0.5 | -83.7% | — | -74.4% | — |
| BTMD | — | 3.5 | -2.5% | 14.1% | -32.9% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 14
| Métrica | Tendencia | 2025 |
|---|---|---|
| Revenue | $0 | |
| R&D Expense | $49M | |
| SG&A Expense | $14M | |
| Operating Expenses | $63M | |
| Operating Income | $-63M | |
| Interest Income | $5M | |
| Other Non-op | $5M | |
| Income Tax | $0 | |
| Net Income | $-58M | |
| EPS (Basic) | $-2.93 | |
| EPS (Diluted) | $-2.93 | |
| Shares (Basic) | 19,624,626 | |
| Shares (Diluted) | 19,624,626 | |
| EBITDA | $-63M |
Balance general 18
| Métrica | Tendencia | 2025 |
|---|---|---|
| Cash & Equivalents | $47M | |
| Short-term Investments | $63M | |
| Prepaid Expense | $2M | |
| Current Assets | $112M | |
| Other Non-current Assets | $5M | |
| Total Assets | $117M | |
| Accounts Payable | $2M | |
| Accrued Liabilities | $8M | |
| Current Liabilities | $11M | |
| Capital Leases | $0 | |
| Other Non-current Liabilities | $0 | |
| Total Liabilities | $11M | |
| Common Stock | $0 | |
| Retained Earnings | $-116M | |
| AOCI | $81.0K | |
| Stockholders' Equity | $107M | |
| Liabilities + Equity | $117M | |
| Shares Outstanding | 21,815,353 |
Flujo de Efectivo 10
| Métrica | Tendencia | 2025 |
|---|---|---|
| D&A | $36.0K | |
| Stock-based Comp | $4M | |
| Other Non-cash | $-565.0K | |
| Operating Cash Flow | $-54M | |
| CapEx | $95.0K | |
| Investing Cash Flow | $-50M | |
| Stock Issued | $195.0K | |
| Net Stock Activity | $195.0K | |
| Financing Cash Flow | $89M | |
| Free Cash Flow | $-54M |
Rentabilidad 2
| Métrica | Tendencia | 2025 |
|---|---|---|
| ROA | -59.2% | |
| ROE | -47.3% |
Liquidez y Solvencia 2
| Métrica | Tendencia | 2025 |
|---|---|---|
| Current Ratio | 10.6 | |
| Quick Ratio | 10.4 |
Eficiencia 1
| Métrica | Tendencia | 2025 |
|---|---|---|
| Asset Turnover | 0.0 |
Valoración (TTM) 9
| Métrica | Tendencia | 2025 |
|---|---|---|
| Revenue TTM | $0 | |
| Net Income TTM | $-58M | |
| Market Cap | $286M | |
| P/E | -4.5 | |
| P/B | 2.7 | |
| P / Tangible Book | 2.7 | |
| P / Cash Flow | -5.3 | |
| P / FCF | -5.3 | |
| Earnings Yield | -22.3% |
Estado de resultados 13
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | |
| R&D Expense | $17M | $14M | $14M | $13M | $8M | |
| SG&A Expense | $6M | $4M | $4M | $3M | $3M | |
| Operating Expenses | $22M | $19M | $18M | $16M | $10M | |
| Operating Income | $-22M | $-19M | $-18M | $-16M | $-10M | |
| Interest Income | $889.0K | $1M | $1M | $1M | $1M | |
| Other Non-op | $876.0K | $1M | $1M | $1M | $1M | |
| Net Income | $-22M | $-18M | $-16M | $-14M | $-9M | |
| EPS (Basic) | $-0.99 | $-0.81 | $-0.75 | $-0.66 | $-0.71 | |
| EPS (Diluted) | $-0.99 | $-0.81 | $-0.75 | $-0.66 | $-0.71 | |
| Shares (Basic) | 21,815,995 | -36,974,225 | 21,713,858 | 21,690,275 | 13,194,718 | |
| Shares (Diluted) | 21,815,995 | -36,974,225 | 21,713,858 | 21,690,275 | 13,194,718 | |
| EBITDA | $-22M | · | $-18M | $-16M | $-10M |
Balance general 18
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $62M | $47M | $39M | $26M | $27M | |
| Short-term Investments | $29M | $63M | $87M | $116M | $125M | |
| Prepaid Expense | $2M | $2M | $3M | $3M | $3M | |
| Current Assets | $94M | $112M | $129M | $145M | $155M | |
| Other Non-current Assets | $5M | $5M | $4M | $2M | $2M | |
| Total Assets | $99M | $117M | $133M | $147M | $157M | |
| Accounts Payable | $4M | $2M | $4M | $5M | $3M | |
| Accrued Liabilities | $7M | $8M | $6M | $5M | $3M | |
| Current Liabilities | $12M | $11M | $11M | $10M | $6M | |
| Capital Leases | · | $0 | $116.0K | $228.0K | $336.0K | |
| Other Non-current Liabilities | · | $0 | $0 | $12.0K | $24.0K | |
| Total Liabilities | $12M | $11M | $11M | $11M | $6M | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | |
| Retained Earnings | $-138M | $-116M | $-98M | $-82M | $-68M | |
| AOCI | $14.0K | $81.0K | $82.0K | $-3.0K | $44.0K | |
| Stockholders' Equity | $87M | $107M | $122M | $137M | $151M | |
| Liabilities + Equity | $99M | $117M | $133M | $147M | $157M | |
| Shares Outstanding | 21,816,385 | 21,815,353 | 21,745,265 | 21,693,016 | 21,688,172 |
Flujo de Efectivo 8
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| D&A | $11.0K | $10.0K | $10.0K | $11.0K | $5.0K | |
| Stock-based Comp | $2M | $2M | $2M | $634.0K | $233.0K | |
| Other Non-cash | $704.0K | · | · | · | $-2M | |
| Operating Cash Flow | $-19M | $-17M | $-16M | $-10M | $-11M | |
| CapEx | · | $0 | $4.0K | $91.0K | $0 | |
| Investing Cash Flow | $34M | $24M | $29M | $9M | $-113M | |
| Financing Cash Flow | $4.0K | $274.0K | $171.0K | $-71.0K | $89M | |
| Free Cash Flow | · | · | · | · | $-11M |
Rentabilidad 2
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| ROA | -16.9% | · | -24.5% | -19.5% | -11.9% | |
| ROE | -18.2% | · | -26.7% | -21.0% | -12.4% |
Liquidez y Solvencia 2
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Current Ratio | 8.1 | · | 12.0 | 14.0 | 25.9 | |
| Quick Ratio | 7.9 | · | 11.8 | 13.8 | 25.3 |
Eficiencia 1
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | · | 0.0 |
Valoración (TTM) 8
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Net Income TTM | $-62M | · | $-44M | $-33M | $-21M | |
| Market Cap | $82M | · | $289M | $293M | $163M | |
| P/E | -1.2 | · | -4.2 | -3.6 | -2.0 | |
| P/B | 0.9 | · | 2.4 | 2.1 | 1.1 | |
| P / Tangible Book | 0.9 | · | 2.4 | 2.1 | 1.1 | |
| P / Cash Flow | -4.4 | · | · | · | -14.3 | |
| P / FCF | · | · | · | · | -14.3 | |
| Earnings Yield | -82.5% | · | -23.8% | -28.0% | -49.0% |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Ingresos | $0 | — |
| Beneficio neto | $-58M | $-21M |
| EPS Diluido | $-2.93 | $-5.15 |
Balance general
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Ratio corriente | 10.6 | — |
| Ratio Rápido | 10.4 | — |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Flujo de caja libre | $-54M | — |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.